ABUS vs ICCM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

ABUS

51.2
AI Score
VS
ABUS Wins

ICCM

47.4
AI Score

Investment Advisor Scores

ABUS

51score
Recommendation
HOLD

ICCM

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABUS ICCM Winner
Revenue 14.08M 3.38M ABUS
Net Income -33.50M -15.06M ICCM
Net Margin -237.9% -445.6% ABUS
Operating Income -38.16M -15.09M ICCM
ROE -43.7% -166.4% ABUS
ROA -35.4% -108.4% ABUS
Total Assets 94.62M 13.89M ABUS
Cash 18.01M 8.90M ABUS
Current Ratio 15.73 2.61 ABUS

Relative Price Performance (Last 90 Days)

ABUS 1M: -10.5% · 3M: +0.9% ICCM 1M: -48.1% · 3M: +822.7%

Current Technical Phase

ABUS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.3 · Price: $4.36

ICCM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.7 · Price: $2.78

Fundamentals Snapshot

Metric ABUS ICCM
Market Cap
Forward P/E -35.2 -0.7
Trailing P/E 5.2
Revenue (TTM)
Revenue Growth 100.5% 0.3%
Gross Margin 0.9% 0.4%
Operating Margin 0.9% -4.7%
EPS 0.83 -7.20
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ABUS is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.